ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

JIRLS. 2023; 5(1): 27-31


ANTI-DIABETIC ACTIVITY OF Momordica charantia AND Morinda citrifolia USING TWO ENZYME INHIBITORY ASSAYS

Abuga I., Keta J.N., Gudu G.J., Shehu M., Aliero A.A., Bagudo A.I., Sa’adu M., Jibo G.G..



Abstract
Download PDF Post

Plants extracts that are capable of inhibiting carbohydrate-hydrolyzing enzymes such as α-glucosidase and α-amylase can be employed to reduce diabetes which triggers glucose elevation and subsequent oxidative stress. In this study, the inhibitory activity of the methanolic leaf extracts of Momordica charantia and Morinda citrifolia using two enzyme inhibitory assays (α-amylase and α-glucosidase) were determined. The extracts of M. charantia was found to have the highest anti-diabetic activity with an average α-glucosidase inhibition value of 59.00 ± 8.07% at 2.5 mg/mL. No activity was observed with the extract of M. citrifolia for the α-glucosidase assay. For the α-amylase, the highest inhibition value (24.56 ± 1.21%) was observed with the extract of M. charantia at the concentration of 10 mg/mL. The result obtained from this study may strengthen the scientific proof on the medicinal values of the plant extract.

Key words: Anti-diabetic, α-amylase, α-glucosidase, Momordica charantia, Morinda citrifolia





Bibliomed Article Statistics

21
28
50
60
57
32
31
21
30
20
20
18
R
E
A
D
S

25

17

17

45

19

8

18

13

12

17

20

20
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.